What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Hepatology is the Service with the highest participation in clinical trials of liver diseases in Spain The Hepatology Service is currently participating in 74 clinical trials, of which 50 are commercial. News A Vall d'Hebron study opens the door to personalized medicine in migraine The results show that there are two types of migraine attacks depending on whether CGRP levels increase or not during the acute phase. News A new targeted nanosystem improves brain drug delivery for the treatment after a stroke Direct brain administration through the carotid artery of nanomaterials carrying drugs that boost tissue recovery could be an effective method to reduce the undesirable effects in other organs and improve the arrival of the drug into the brain. News VHIR participates in the Tartaglia project: networked artificial intelligence to accelerate clinical and health research The objective of the Tartaglia project will be to train mathematical models to support decision making and contribute to personalized and precision medicine. News Developing New Technologies & Diagnostic Tools for B-Cell Monitoring in Transplant Rejection Vall d'Hebron has announced a research collaboration with Pure Transplant Solutions, LLC (PTS) led by Dr. Oriol Bestard, head of the Nephrology and Kidney Transplant group at VHIR. News Vall d’Hebron se suma al Dia Internacional del Càncer Infantil i referma l’aposta per la medicina personalitzada Som centre estatal de referència per al trasplantament de progenitors hematopoètics o cèl·lules mare, amb 1.417 trasplantaments realitzats: fa una dècada que vam obtenir l’acreditació JACIE, la més prestigiosa de l’àmbit europeu. News Vall d’Hebron unveils a mural dedicated to female scientists The artwork Pioneres, presented on the International Day of Women and Girls in Science, is almost 40 metres long and portrays nine women, from Ancient Greece to the present day, who have contributed to the progress of sciences in the field of health. Activities Defensa de tesi "Neuropathological and molecular alterations in a novel neuromelanin-producing transgenic mouse model: relevance to Parkinson's disease and brain aging" Doctoranda: Núria Peñuelas Peñarroya, grup de Recerca de Malalties neurodegeneratives (VHIR) Directors: Dr. Miquel Vila Bover i Dra. Ariadna Laguna Tuset Tutor: Dr. Joan Xavier Comella Carnicé News A project led by Laia Ventura, a Vall d'Hebron nurse, wins an award from the General Council of Nursing The work "Family presence during invasive procedures in pediatrics: perceptions, attitudes and practices of nurses" has received the Research Award of the General Council of Nursing in the category of Young Promises in Nursing Research. News Vall d’Hebron renews its accreditation as a centre committed to excellence in nursing The recognition awards the Health Care Research Unit the prestigious RNAO and acknowledges the Hospital’s contribution and commitment to implementing the Best Practice Guidelines. News Colorectal cancers raise defensive barrier in response to chemotherapy Dr. Gerard Cantero, who is now a researcher at the CIBBIM-Nanomedicine -Kidney Physiopathology at VHIR, participated in the work led by CRG and IMIM. News Precision medicine and innovation in research, protagonists at the World Cancer Day Conference The Vall d’Hebron Barcelona Hospital Campus has organised the World Cancer Day Conference as part of World Cancer Day, today, 4 February. News Stable nanovesicles for the delivery of microRNA in cancer treatment It is first proof of concept for the delivery of a tumor-suppressive microRNA for the treatment of neuroblastoma, a highly-aggressive pediatric solid tumor of the peripheral nervous system. News Vall d’Hebron participates in RESPONSE, a global phase III clinical trial for the treatment of primary biliary cholangitis The innovative oral drug could provide a new therapeutic option for people with PBC who have not obtained the recommended therapeutic outcome or who do not tolerate first line therapy and cannot continue their treatment. News Llistes de priorització de la Beca FI de l’AGAUR Ens plau comunicar que la Comissió Avaluadora Interna ha finalitzat el procés de valoració de les al·legacions presentades en relació a la priorització de persones candidates als Ajuts AGAUR FI-DGR 2022. News Kern Pharma and Mi Compañero de Viaje donate €16,026 for research into paediatric sarcomas at Vall d’Hebron The donation will boost the research headed by Dr Josep Roma, researcher with the VHIR Childhood Cancer and Haematological Diseases group. News Recruitment of volunteers starts for the Phase III clinical trial of the HIPRA COVID-19 vaccine The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy. News The journal Nature publishes a review of severe COVID-19-related factors with the participation of Vall d’Hebron The publication summarises the main results showing that at least 20% of cases of severe pneumonia after SARS-CoV-2 infection are explained by genetic and immunological anomalies. News A Vall d’Hebron study relates the impact of obesity to cognitive impairment The mechanisms in obesity that cause mild cognitive impairment are similar to those of type 2 diabetes. Fat is a powerful cerebral toxin and risk factor: it causes delayed reaction times in both executive function and attention. News Researchers identify a molecule that could be involved in the formation of bone metastases in prostate cancer A group of researchers from Vall d’Hebron Research, IDIBELL and UB has identified a molecule involved in bone metastasis associated with prostate cancer that could be useful in the design of new therapies for its treatment. Pagination First page « Previous page ‹ … Page 49 Page 50 Current page 51 Page 52 Page 53 … Next page › Last page »
